Literature DB >> 24610932

Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells.

Aravind Cherukuri1, David M Rothstein2, Brendan Clark3, Clive R Carter3, Adam Davison4, Maria Hernandez-Fuentes5, Eric Hewitt6, Alan D Salama7, Richard J Baker8.   

Abstract

Human B cells with immunoregulatory properties in vitro (Bregs) have been defined by the expression of IL-10 and are enriched in various B-cell subsets. However, proinflammatory cytokine expression in B-cell subsets is largely unexplored. We examined the cytokine profiles of human PBMCs and found that subsets of CD24(hi)CD38(hi) transitional B cells (TrBs), CD24(hi)CD27(+) memory B cells, and naïve B cells express IL-10 and the proinflammatory cytokine TNF-α simultaneously. TrBs had the highest IL-10/TNF-α ratio and suppressed proinflammatory helper T cell 1 (Th1) cytokine expression by autologous T cells in vitro more potently than memory B cells did, despite similar IL-10 expression. Whereas neutralization of IL-10 significantly inhibited TrB-mediated suppression of autologous Th1 cytokine expression, blocking TNF-α increased the suppressive capacity of both memory and naïve B-cell subsets. Thus, the ratio of IL-10/TNF-α expression, a measure of cytokine polarization, may be a better indicator of regulatory function than IL-10 expression alone. Indeed, compared with TrB cells from patients with stable kidney graft function, TrBs from patients with graft rejection displayed similar IL-10 expression levels but increased TNF-α expression (i.e., reduced IL-10/TNF-α ratio), did not inhibit in vitro expression of Th1 cytokines by T cells, and abnormally suppressed expression of Th2 cytokines. In patients with graft dysfunction, a low IL-10/TNF-α ratio in TrBs associated with poor graft outcomes after 3 years of follow-up. In summary, these results indicate that B cell-mediated immune regulation is best characterized by the cytokine polarization profile, a finding that was confirmed in renal transplant patients.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  chronic allograft rejection; immunology; renal function decline

Mesh:

Substances:

Year:  2014        PMID: 24610932      PMCID: PMC4073434          DOI: 10.1681/ASN.2013080837

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

1.  Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi; Hidetoshi Takedatsu; Richard S Blumberg; Atul K Bhan
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

Review 2.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

3.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.

Authors:  Takashi Matsushita; Koichi Yanaba; Jean-David Bouaziz; Manabu Fujimoto; Thomas F Tedder
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

4.  Revisiting the Natural History of IF/TA in Renal Transplantation.

Authors:  Sophie Brouard; Karine Renaudin; Jean-Paul Soulillou
Journal:  Am J Transplant       Date:  2011-04       Impact factor: 8.086

5.  B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis.

Authors:  Monica K Mann; Katarzyna Maresz; Leah P Shriver; Yanping Tan; Bonnie N Dittel
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

6.  Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.

Authors:  M Gray; K Miles; D Salter; D Gray; J Savill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

7.  B cells regulate autoimmunity by provision of IL-10.

Authors:  Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

8.  Complement-binding anti-HLA antibodies and kidney-allograft survival.

Authors:  Alexandre Loupy; Carmen Lefaucheur; Dewi Vernerey; Christof Prugger; Jean-Paul Duong van Huyen; Nuala Mooney; Caroline Suberbielle; Véronique Frémeaux-Bacchi; Arnaud Méjean; François Desgrandchamps; Dany Anglicheau; Dominique Nochy; Dominique Charron; Jean-Philippe Empana; Michel Delahousse; Christophe Legendre; Denis Glotz; Gary S Hill; Adriana Zeevi; Xavier Jouven
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

Review 9.  Activating systemic autoimmunity: B's, T's, and tolls.

Authors:  Mark J Shlomchik
Journal:  Curr Opin Immunol       Date:  2009-09-30       Impact factor: 7.486

10.  Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus.

Authors:  Wojciech Wojciechowski; David P Harris; Frank Sprague; Betty Mousseau; Melissa Makris; Kim Kusser; Tasuko Honjo; Katja Mohrs; Markus Mohrs; Troy Randall; Frances E Lund
Journal:  Immunity       Date:  2009-02-26       Impact factor: 31.745

View more
  43 in total

Review 1.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

2.  Rictor deficiency in dendritic cells exacerbates acute kidney injury.

Authors:  Helong Dai; Alicia R Watson; Daniel Fantus; Longkai Peng; Angus W Thomson; Natasha M Rogers
Journal:  Kidney Int       Date:  2018-09-04       Impact factor: 10.612

3.  B cells and kidney transplantation: beyond antibodies.

Authors:  Anita Mehrotra; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2014-03-07       Impact factor: 10.121

4.  Immunology: TREG cells in transplantation-a double-edged sword?

Authors:  Fadi G Lakkis
Journal:  Nat Rev Nephrol       Date:  2014-03-11       Impact factor: 28.314

5.  Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.

Authors:  Estefania Nova-Lamperti; Prabhjoat Chana; Paula Mobillo; Manohursingh Runglall; Yogesh Kamra; Reuben McGregor; Graham M Lord; Robert I Lechler; Giovanna Lombardi; Maria P Hernandez-Fuentes
Journal:  Transplantation       Date:  2017-03       Impact factor: 4.939

Review 6.  Role of B cells in tolerance induction.

Authors:  James I Kim; David M Rothstein; James F Markmann
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 7.  Human regulatory B cells in health and disease: therapeutic potential.

Authors:  Claudia Mauri; Madhvi Menon
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

8.  Complete B Cell Deficiency Reduces Allograft Inflammation and Intragraft Macrophages in a Rat Kidney Transplant Model.

Authors:  Sarah E Panzer; Nancy A Wilson; Bret M Verhoven; Ding Xiang; C Dustin Rubinstein; Robert R Redfield; Weixiong Zhong; Shannon R Reese
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

9.  Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.

Authors:  Mélanie Chesneau; Laure Michel; Emilie Dugast; Alexis Chenouard; Daniel Baron; Annaïck Pallier; Justine Durand; Faouzi Braza; Pierrick Guerif; David-Axel Laplaud; Jean-Paul Soulillou; Magali Giral; Nicolas Degauque; Elise Chiffoleau; Sophie Brouard
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

10.  Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation.

Authors:  Jinghui Yang; Jianjun Chen; James S Young; Qiang Wang; Dengping Yin; Roger Sciammas; Anita S Chong
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.